The Venture Codex Logo

The Venture Codex

Overview

Provider of heart valve technologies and hemodynamic monitoring solutions.

Founded

1958

Deals · 12mo

0

Stage focus

Series B

Geographic focus

France
Israel
United States

Sector focus

Biotechnology
Health Care
Medical
Medical Device

Investment portfolio

7rounds
NAMEDATESIZE
Carvolix
Jul 2024Led
$5 MOther Equity
Corvia Medical
Jun 2022Participated
$54 MOther Equity
Caption Health
Jul 2020Participated
$53 MSeries B
V-Wave
Apr 2018Participated
$70 MSeries C
V-Wave
Jan 2016Participated
$28 MSeries B
CardioKinetix
Dec 2014Led
$50 MOther Equity
Middle Peak Medical
Oct 2013Participated
$3 MSeries A
Carvolix
Jul 2024Led
$5 MOther Equity
Corvia Medical
Jun 2022Participated
$54 MOther Equity
Caption Health
Jul 2020Participated
$53 MSeries B
V-Wave
Apr 2018Participated
$70 MSeries C
V-Wave
Jan 2016Participated
$28 MSeries B
CardioKinetix
Dec 2014Led
$50 MOther Equity
Middle Peak Medical
Oct 2013Participated
$3 MSeries A
7
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Edwards Lifesciences: 7 funding rounds are recorded in the selected participation categories.All available history.
Edwards Lifesciences: 7 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A01
Series B02
Series C+01
Other Equity21

Monthly Deal Activity

Edwards Lifesciences: 7 deals are recorded across 157 months.All available history.
Edwards Lifesciences: 7 deals are recorded across 157 months. All available history
MonthDeals
Oct '131
Nov '130
Dec '130
Jan '140
Feb '140
Mar '140
Apr '140
May '140
Jun '140
Jul '140
Aug '140
Sep '140
Oct '140
Nov '140
Dec '141
Jan '150
Feb '150
Mar '150
Apr '150
May '150
Jun '150
Jul '150
Aug '150
Sep '150
Oct '150
Nov '150
Dec '150
Jan '161
Feb '160
Mar '160
Apr '160
May '160
Jun '160
Jul '160
Aug '160
Sep '160
Oct '160
Nov '160
Dec '160
Jan '170
Feb '170
Mar '170
Apr '170
May '170
Jun '170
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '181
May '180
Jun '180
Jul '180
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '201
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '221
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '241
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Edwards Lifesciences: Health & Life Sciences is the largest displayed sector by deal count (7 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Edwards Lifesciences: Health & Life Sciences is the largest displayed sector by deal count (7 deals). All available history
SectorDeals
Health & Life Sciences7
AI & Machine Learning1

Deal Size Distribution

Edwards Lifesciences: 7 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Edwards Lifesciences: 7 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M1
$5M-$10M1
$10M-$25M0
$25M-$50M1
$50M-$100M4
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Edwards Lifesciences: United States has the largest recorded deal count among the displayed regions (4 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

Edwards Lifesciences: United States has the largest recorded deal count among the displayed regions (4 deals). All available history
RegionDeals
United States4
Israel2
Europe1
Edwards Lifesciences: 20 co-investors are shown, with BioStar Ventures sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

Edwards Lifesciences: Led accounts for 29% and participating for 71% of round participation.All available history.
Edwards Lifesciences: Led accounts for 29% and participating for 71% of round participation. All available history
CategoryDeals (count)Share (%)
Led229%
Participating571%
Edwards Lifesciences: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
Edwards Lifesciences: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead2100%
Co-led00%

Team

Christian Potes

Senior Director Applied Machine Learning Group

Dirk Rassloff

Vice President Strategic Marketing, Surgical Structural Heart, Asia at Edwards Lifesciences

Farzad Azimpour

Senior Vice President, Strategic Innovation, Advanced Technology

Murali Reddi

Principal, Medical Safety Officer

Nikolas Rizos

Strategy / Business Intelligence TMTT EU

Nolan Sardesai

Sr. Product Manager

Shane Gleason

Senior Director, US Marketing- Transcatheter Heart Valves

Uzair Siddiqui

Leader, Strategic Program Management